Searching News Database: colon cancer
HSMN NewsFeed - 23 Dec 2022
Hyphens Pharma Licenses Winlevi(R) for All 10 ASEAN countries from Cosmo Pharmaceuticals
Hyphens Pharma Licenses Winlevi(R) for All 10 ASEAN countries from Cosmo Pharmaceuticals
HSMN NewsFeed - 7 Oct 2020
Exact Sciences and Pfizer Extend and Amend Cologuard(R) Promotion Agreement
Exact Sciences and Pfizer Extend and Amend Cologuard(R) Promotion Agreement
HSMN NewsFeed - 26 May 2020
SMART Medical Systems Receives FDA Clearance for Its G-EYE(R) Colonoscope
SMART Medical Systems Receives FDA Clearance for Its G-EYE(R) Colonoscope
HSMN NewsFeed - 13 May 2019
Check-Cap Announces Second Trial Site Joins Ongoing U.S. Pilot Study of C-Scan(R)
Check-Cap Announces Second Trial Site Joins Ongoing U.S. Pilot Study of C-Scan(R)
HSMN NewsFeed - 12 Feb 2019
Check-Cap Announces Institutional Review Board Approval to Initiate U.S. Pilot Study of C-Scan(R)
Check-Cap Announces Institutional Review Board Approval to Initiate U.S. Pilot Study of C-Scan(R)
HSMN NewsFeed - 11 Apr 2018
Sysmex Inostics: OncoBEAM(TM) RAS CRC Liquid Biopsy Test Now Reimbursed in Germany by BARMER
Sysmex Inostics: OncoBEAM(TM) RAS CRC Liquid Biopsy Test Now Reimbursed in Germany by BARMER
HSMN NewsFeed - 21 Mar 2018
Cernostics Raises $2.5 Million in Series A1 Financing, Led by Illumina Ventures
Cernostics Raises $2.5 Million in Series A1 Financing, Led by Illumina Ventures
HSMN NewsFeed - 25 Sep 2017
Bracco Diagnostics Inc. Receives U.S. FDA Approval for TAGITOL(TM) V (Barium Sulfate) Oral Suspension
Bracco Diagnostics Inc. Receives U.S. FDA Approval for TAGITOL(TM) V (Barium Sulfate) Oral Suspension
HSMN NewsFeed - 4 Nov 2016
Boston Scientific Announces Extension of the Cash Tender Offer for All Shares of EndoChoice
Boston Scientific Announces Extension of the Cash Tender Offer for All Shares of EndoChoice
HSMN NewsFeed - 3 Nov 2016
Boston Scientific Announces Acquisition Of The LumenR(TM) Tissue Retractor System
Boston Scientific Announces Acquisition Of The LumenR(TM) Tissue Retractor System
HSMN NewsFeed - 7 Oct 2016
Boston Scientific Commences Cash Tender Offer For All Shares Of EndoChoice For $8.00 Per Share In Cash
Boston Scientific Commences Cash Tender Offer For All Shares Of EndoChoice For $8.00 Per Share In Cash
HSMN NewsFeed - 26 Jul 2016
Exact Sciences Completes 54,000 Cologuard Tests during the Second Quarter
Exact Sciences Completes 54,000 Cologuard Tests during the Second Quarter
HSMN NewsFeed - 20 May 2016
EndoChoice(R) Launches Third Generation Fuse(R) Full Spectrum Endoscopy(R) System
EndoChoice(R) Launches Third Generation Fuse(R) Full Spectrum Endoscopy(R) System
HSMN NewsFeed - 25 Jan 2016
Exact Sciences Announces Appointment of John A. Fallon, M.D., to Company's Board of Directors
Exact Sciences Announces Appointment of John A. Fallon, M.D., to Company's Board of Directors
HSMN NewsFeed - 7 Jan 2016
EndoChoice(R) Enters Distribution Agreement with Chindex Medical Ltd. for China
EndoChoice(R) Enters Distribution Agreement with Chindex Medical Ltd. for China
HSMN NewsFeed - 31 Mar 2015
EDP Biotech Signs Distribution Partnership Agreements for ColoMarker(R) Abroad
EDP Biotech Signs Distribution Partnership Agreements for ColoMarker(R) Abroad
HSMN NewsFeed - 14 Aug 2014
FDA Approves Genentech’s Avastin Plus Chemotherapy for Treatment of Advanced Cervical Cancer
FDA Approves Genentech’s Avastin Plus Chemotherapy for Treatment of Advanced Cervical Cancer
HSMN NewsFeed - 30 Jul 2014
invendo medical Appoints Nachum (Homi) Shamir to the Company's Board of Directors
invendo medical Appoints Nachum (Homi) Shamir to the Company's Board of Directors
HSMN NewsFeed - 22 Jul 2014
FDA Grants Genentech’s Avastin Priority Review for Recurrent Platinum-Resistant Ovarian Cancer
FDA Grants Genentech’s Avastin Priority Review for Recurrent Platinum-Resistant Ovarian Cancer
HSMN NewsFeed - 15 Jul 2014
FDA Grants Genentech’s Avastin Priority Review for Certain Types of Cervical Cancer
FDA Grants Genentech’s Avastin Priority Review for Certain Types of Cervical Cancer
HSMN NewsFeed - 2 Jun 2014
Myriad Presents Clinical Data on Myriad myRisk(TM) Hereditary Cancer Test at ASCO
Myriad Presents Clinical Data on Myriad myRisk(TM) Hereditary Cancer Test at ASCO
HSMN NewsFeed - 3 Feb 2014
Given Imaging Receives FDA Clearance for PillCam(R) COLON in Patients Following Incomplete Colonoscopy
Given Imaging Receives FDA Clearance for PillCam(R) COLON in Patients Following Incomplete Colonoscopy
HSMN NewsFeed - 11 Nov 2013
Given Imaging Receives Reimbursement Approval for PillCam COLON(R) in Japan Effective January 1, 2014
Given Imaging Receives Reimbursement Approval for PillCam COLON(R) in Japan Effective January 1, 2014
HSMN NewsFeed - 24 Oct 2013
Myriad myRisk(TM) Hereditary Cancer Test Is Highly Accurate in Key Validation Study
Myriad myRisk(TM) Hereditary Cancer Test Is Highly Accurate in Key Validation Study
HSMN NewsFeed - 1 Oct 2013
First urine-based cancer mutation monitoring test available from Trovagene
First urine-based cancer mutation monitoring test available from Trovagene
HSMN NewsFeed - 26 Aug 2013
GeneDx Introduces Advanced Genetic Test Panels for Inherited Cancer Including Breast and Colon Cancer
GeneDx Introduces Advanced Genetic Test Panels for Inherited Cancer Including Breast and Colon Cancer
HSMN NewsFeed - 15 Jul 2013
Given Imaging's PillCam(R) COLON Cleared in Japan, World's Second Largest Healthcare Market
Given Imaging's PillCam(R) COLON Cleared in Japan, World's Second Largest Healthcare Market
HSMN NewsFeed - 27 Nov 2012
Given Imaging Submits PillCam(R) COLON 2 Application to FDA for U.S. Regulatory Clearance
Given Imaging Submits PillCam(R) COLON 2 Application to FDA for U.S. Regulatory Clearance
HSMN NewsFeed - 18 Oct 2012
A.P. Pharma Appoints Robert Rosen as Senior Vice President and Chief Commercial Officer
A.P. Pharma Appoints Robert Rosen as Senior Vice President and Chief Commercial Officer
HSMN NewsFeed - 27 Sep 2012
Bayer's Stivarga(R) (regorafenib) Tablets Approved by U.S. FDA for Treatment of Metastatic Colorectal Cancer
Bayer's Stivarga(R) (regorafenib) Tablets Approved by U.S. FDA for Treatment of Metastatic Colorectal Cancer
HSMN NewsFeed - 9 Jul 2012
Agendia Names Industry Veteran Glen Fredenberg CFO and Vice President of Finance
Agendia Names Industry Veteran Glen Fredenberg CFO and Vice President of Finance
HSMN NewsFeed - 1 Jun 2012
Agendia Announces Launch of ColoPrint for Colon Cancer Prognosis and Prediction
Agendia Announces Launch of ColoPrint for Colon Cancer Prognosis and Prediction
HSMN NewsFeed - 22 May 2012
New Studies Confirm Given Imaging's PillCam(R) COLON 2's Feasibility in an Outpatient Setting
New Studies Confirm Given Imaging's PillCam(R) COLON 2's Feasibility in an Outpatient Setting
HSMN NewsFeed - 12 Mar 2012
Synta Announces Appointment of Dvorit Samid, Ph.D., as Vice President, Medical Affairs
Synta Announces Appointment of Dvorit Samid, Ph.D., as Vice President, Medical Affairs
HSMN NewsFeed - 24 Feb 2012
invendo medical Announces 510(k) Clearance by FDA for Advancement-Assisted Single-Use Colonoscopy System
invendo medical Announces 510(k) Clearance by FDA for Advancement-Assisted Single-Use Colonoscopy System
HSMN NewsFeed - 9 Jan 2012
FDA Clears Apollo Endosurgery's SuMO(TM) Endoscopic Tissue Access and Resection System
FDA Clears Apollo Endosurgery's SuMO(TM) Endoscopic Tissue Access and Resection System
HSMN NewsFeed - 4 Jan 2012
Given Imaging Provides Update on PillCam(R) COLON 2 Pivotal Trial Enrollment
Given Imaging Provides Update on PillCam(R) COLON 2 Pivotal Trial Enrollment
HSMN NewsFeed - 29 Jun 2011
iCAD’s VeraLook(R) for CT Colonography Now Available with Vital Images’ Products
iCAD’s VeraLook(R) for CT Colonography Now Available with Vital Images’ Products
HSMN NewsFeed - 6 Jun 2011
Given Imaging Initiates 800-Patient Multi-Center, Pivotal Trial for PillCam(R) COLON 2
Given Imaging Initiates 800-Patient Multi-Center, Pivotal Trial for PillCam(R) COLON 2
HSMN NewsFeed - 20 May 2011
SUTENT(R) Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors
SUTENT(R) Receives U.S. FDA Approval For Advanced Pancreatic Neuroendocrine Tumors
HSMN NewsFeed - 15 Mar 2011
Breakthrough Light-Activated Drug-Device to be Investigated for Treatment of HPV* and Cervical Pre-cancer
Breakthrough Light-Activated Drug-Device to be Investigated for Treatment of HPV* and Cervical Pre-cancer
HSMN NewsFeed - 10 Mar 2011
Given Imaging Receives FDA Clearance for Expanded PillCam(R) SB Indications
Given Imaging Receives FDA Clearance for Expanded PillCam(R) SB Indications
HSMN NewsFeed - 2 Mar 2011
iCAD Features Image Analysis Solutions for Breast, Prostate and Colon Cancer Detection at the ECR 2011
iCAD Features Image Analysis Solutions for Breast, Prostate and Colon Cancer Detection at the ECR 2011
HSMN NewsFeed - 8 Feb 2011
Given Imaging's PillCam(R) COLON Now Reimbursable for Hospital Inpatient Use in Germany
Given Imaging's PillCam(R) COLON Now Reimbursable for Hospital Inpatient Use in Germany
HSMN NewsFeed - 1 Dec 2010
Florida Surgeon Completes World’S First Gastric Band with Spider(R) System
Florida Surgeon Completes World’S First Gastric Band with Spider(R) System
HSMN NewsFeed - 19 Oct 2010
Devon Medical Products Receives FDA 510(k) Clearance for CircuFlow Sequential Compression Pump Models
Devon Medical Products Receives FDA 510(k) Clearance for CircuFlow Sequential Compression Pump Models
HSMN NewsFeed - 4 Aug 2010
iCAD Announces FDA Clearance of the Company's Computer-Aided Detection Product for Virtual Colonoscopy
iCAD Announces FDA Clearance of the Company's Computer-Aided Detection Product for Virtual Colonoscopy
HSMN NewsFeed - 12 Jul 2010
Clarient Announces Publication of Mammostrat(R) Breast Cancer Study in Breast Cancer Research
Clarient Announces Publication of Mammostrat(R) Breast Cancer Study in Breast Cancer Research
HSMN NewsFeed - 1 Jun 2010
Lorus Therapeutics Files Investigational New Drug Application With FDA for Anticancer Drug LOR-253
Lorus Therapeutics Files Investigational New Drug Application With FDA for Anticancer Drug LOR-253
HSMN NewsFeed - 5 May 2010
New Studies Presented at Digestive Disease Week Highlight the Value of PillCam(R) Capsule Endoscopy
New Studies Presented at Digestive Disease Week Highlight the Value of PillCam(R) Capsule Endoscopy
HSMN NewsFeed - 17 Mar 2010
New Data Indicate Effectiveness of Clarient's Ovotax(TM) Test for Ovarian Cancer
New Data Indicate Effectiveness of Clarient's Ovotax(TM) Test for Ovarian Cancer
HSMN NewsFeed - 21 Jan 2010
Genomic Health Announces Worldwide Availability of the Oncotype DX(R) Colon Cancer Test
Genomic Health Announces Worldwide Availability of the Oncotype DX(R) Colon Cancer Test
HSMN NewsFeed - 21 Jan 2010
IsoRay Announces World's First Cesium-131 Colon Cancer Treatment at Cornell Medical Center
IsoRay Announces World's First Cesium-131 Colon Cancer Treatment at Cornell Medical Center
HSMN NewsFeed - 17 Dec 2009
NiTi Surgical Solutions Announces First Application of ColonRing in China
NiTi Surgical Solutions Announces First Application of ColonRing in China
HSMN NewsFeed - 23 Nov 2009
Given Imaging Launches Next-Generation PillCam(R) COLON 2 at GASTRO 2009 Conference
Given Imaging Launches Next-Generation PillCam(R) COLON 2 at GASTRO 2009 Conference
HSMN NewsFeed - 2 Nov 2009
Calypso Medical Studies Show Potential for Improving Radiotherapy Treatment Accuracy
Calypso Medical Studies Show Potential for Improving Radiotherapy Treatment Accuracy
HSMN NewsFeed - 22 Apr 2009
Phase III C-08 Study of Avastin in Early-Stage Colon Cancer Did Not Meet Primary Endpoint
Phase III C-08 Study of Avastin in Early-Stage Colon Cancer Did Not Meet Primary Endpoint
HSMN NewsFeed - 3 Feb 2009
Warnex Offers New Personalized Medicine Service: K-ras Mutation Analysis for Colorectal Cancer
Warnex Offers New Personalized Medicine Service: K-ras Mutation Analysis for Colorectal Cancer
HSMN NewsFeed - 16 Dec 2008
Generex Biotechnology and Pevion Biotech Announce Plans for Immunotherapeutic Vaccine Collaboration
Generex Biotechnology and Pevion Biotech Announce Plans for Immunotherapeutic Vaccine Collaboration
HSMN NewsFeed - 18 Nov 2008
Medicsight Seeks FDA 510(k) Clearance to Market its ColonCAD(TM) Software in the U.S.
Medicsight Seeks FDA 510(k) Clearance to Market its ColonCAD(TM) Software in the U.S.
HSMN NewsFeed - 20 Oct 2008
Genentech Announces Phase III Study of Avastin Plus Chemotherapy in Adjuvant Colon Cancer Will Continue
Genentech Announces Phase III Study of Avastin Plus Chemotherapy in Adjuvant Colon Cancer Will Continue
HSMN NewsFeed - 16 Sep 2008
ImClone Provides Update on Pivotal Phase 3 CRYSTAL Study in First-Line Metastatic Colorectal Cancer
ImClone Provides Update on Pivotal Phase 3 CRYSTAL Study in First-Line Metastatic Colorectal Cancer
HSMN NewsFeed - 9 Sep 2008
Jennerex Completes $8.3 Million Series B Financing and Appoints Dr. Cal Stiller as Director
Jennerex Completes $8.3 Million Series B Financing and Appoints Dr. Cal Stiller as Director
HSMN NewsFeed - 21 May 2008
AVANT Immunotherapeutics Announces Hart-Scott Rodino Clearance to License Cancer Vaccine to Pfizer
AVANT Immunotherapeutics Announces Hart-Scott Rodino Clearance to License Cancer Vaccine to Pfizer
HSMN NewsFeed - 24 Apr 2008
SpectraScience Secures Distribution for WavSTAT(R) System in Czech Republic
SpectraScience Secures Distribution for WavSTAT(R) System in Czech Republic
HSMN NewsFeed - 20 Mar 2008
Immunomedics Develops New Immunoconjugates for Targeted Chemotherapy of Pancreatic and Other Cancers
Immunomedics Develops New Immunoconjugates for Targeted Chemotherapy of Pancreatic and Other Cancers
HSMN NewsFeed - 25 Feb 2008
Marillion Pharmaceuticals and Cytokine PharmaSciences Announce License Agreement for Xerostomia Treatment
Marillion Pharmaceuticals and Cytokine PharmaSciences Announce License Agreement for Xerostomia Treatment
HSMN NewsFeed - 17 Dec 2007
Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
HSMN NewsFeed - 25 Sep 2007
SpectraScience Appoints the Honorable Tommy Thompson to its Board of Directors
SpectraScience Appoints the Honorable Tommy Thompson to its Board of Directors
HSMN NewsFeed - 20 Sep 2007
CG Therapeutics Appoints Dr. Christopher S. Henney as Chairman of Board of Directors
CG Therapeutics Appoints Dr. Christopher S. Henney as Chairman of Board of Directors
HSMN NewsFeed - 19 Jun 2007
OSI Pharmaceuticals Begins Clinical Development Program of OSI-906 in Patients with Advanced Solid Tumors
OSI Pharmaceuticals Begins Clinical Development Program of OSI-906 in Patients with Advanced Solid Tumors
HSMN NewsFeed - 18 Jun 2007
Health Canada approves new chemotherapy treatment for patients with metastatic colorectal cancer
Health Canada approves new chemotherapy treatment for patients with metastatic colorectal cancer
HSMN NewsFeed - 17 May 2007
Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many Aspects of Daily Life
Ulcerative Colitis (UC) Sufferers Find UC Quite Disruptive to Many Aspects of Daily Life
HSMN NewsFeed - 18 Apr 2007
Wyeth Responds to Special Report Published in New England Journal of Medicine
Wyeth Responds to Special Report Published in New England Journal of Medicine
HSMN NewsFeed - 26 Feb 2007
Novelix Announces Licensing of Cancer Compound to AOP Orphan Pharmaceuticals
Novelix Announces Licensing of Cancer Compound to AOP Orphan Pharmaceuticals
HSMN NewsFeed - 20 Feb 2007
Tapestry Pharmaceuticals Appoints Sandra L. Silberman, M.D., Ph.D. As Chief Medical Officer
Tapestry Pharmaceuticals Appoints Sandra L. Silberman, M.D., Ph.D. As Chief Medical Officer
HSMN NewsFeed - 10 Jan 2007
Bradley Pharmaceuticals Announces Appointment of Dr. Leonard S. Jacob As Non-Executive Chair
Bradley Pharmaceuticals Announces Appointment of Dr. Leonard S. Jacob As Non-Executive Chair
HSMN NewsFeed - 6 Dec 2006
iCAD and Viatronix Announce Product Integration and Distribution Agreement
iCAD and Viatronix Announce Product Integration and Distribution Agreement
HSMN NewsFeed - 9 Nov 2006
NeoGuide Systems Taps Medical Device Industry Veteran as New President and Chief Executive Officer
NeoGuide Systems Taps Medical Device Industry Veteran as New President and Chief Executive Officer
HSMN NewsFeed - 6 Nov 2006
Survival Data Available from Two Randomized ERBITUX Studies in Metastatic Colorectal Cancer
Survival Data Available from Two Randomized ERBITUX Studies in Metastatic Colorectal Cancer
HSMN NewsFeed - 1 Nov 2006
Report Calls for Using Heated Chemotherapy after Colon Cancer Surgery to Optimize Patient Survival
Report Calls for Using Heated Chemotherapy after Colon Cancer Surgery to Optimize Patient Survival
HSMN NewsFeed - 24 Oct 2006
ProNAi Closes Successful Bridge Funding Round, Secures $6.65 Million Total
ProNAi Closes Successful Bridge Funding Round, Secures $6.65 Million Total
HSMN NewsFeed - 23 Oct 2006
Given Imaging Announces Data Presented at American College of Gastroenterology Annual Meeting
Given Imaging Announces Data Presented at American College of Gastroenterology Annual Meeting
HSMN NewsFeed - 9 Oct 2006
GenVec Names Mark O. Thornton, MD, MPH, PhD as Senior Vice President, Clinical Development
GenVec Names Mark O. Thornton, MD, MPH, PhD as Senior Vice President, Clinical Development
HSMN NewsFeed - 27 Sep 2006
FDA Approves Vectibix(TM) to Treat Patients with Metastatic Colorectal Cancer
FDA Approves Vectibix(TM) to Treat Patients with Metastatic Colorectal Cancer
HSMN NewsFeed - 26 Sep 2006
ProNAi Announces Executive Team Buildup, Names New CEO and Top Development Management
ProNAi Announces Executive Team Buildup, Names New CEO and Top Development Management
HSMN NewsFeed - 24 May 2006
Studies Presented at American Urological Association Expand the Role of the NMP22(R) BladderChek(R) Test
Studies Presented at American Urological Association Expand the Role of the NMP22(R) BladderChek(R) Test
HSMN NewsFeed - 23 May 2006
Matritech's NMP22(R) BladderChek(R) Test Can Assist in Early Identification of High Risk Tumors
Matritech's NMP22(R) BladderChek(R) Test Can Assist in Early Identification of High Risk Tumors
HSMN NewsFeed - 23 May 2006
Recruitment to Resume in Avastin International Phase III Trial (AVANT) in Early-Stage Colon Cancer
Recruitment to Resume in Avastin International Phase III Trial (AVANT) in Early-Stage Colon Cancer
HSMN NewsFeed - 23 May 2006
Recruitment Planned to Resume in AVANT International Phase III Trial in Adjuvant Colon Cancer
Recruitment Planned to Resume in AVANT International Phase III Trial in Adjuvant Colon Cancer
HSMN NewsFeed - 10 May 2006
ChondroGene appoints David Tyler Director, Product Development and Quality Assurance
ChondroGene appoints David Tyler Director, Product Development and Quality Assurance
Additional items found! 202
Members Archive contains
202 additional stories matching:
colon cancer
(Password required)
colon cancer
(Password required)